CFO Kaitlyn Arsenault to step down Feb 20; CEO Punit Dhillon appointed principal accounting officer

Skye Bioscience, Inc.

CFO Kaitlyn Arsenault departs Feb 20, 2026; no disagreement with auditors or company on financials.
Severance: $450,000 cash, $45,000 annual bonus, up to $30,000 legal fees, $41,172 COBRA reimbursement.
Arsenault will serve as advisor for 6 months; outstanding equity awards continue vesting.
CEO Punit Dhillon appointed principal accounting officer effective Feb 20; remains CEO and President.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.